It has been tested at very high dosage in other unrelated OA trials. My understanding is higher dosages lead to higher potential incidences of SAE.
Whether one day PAR or others look to up the dosage above known effective levels of 2mg/kg x 2 is something well down the track. For now we just need to pass OA002 primary end points and odds are stacked in our favour with 2mg/kg x 2.
Ann: PAR Successful Placement and Fully Underwritten ANREO, page-191
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.010(3.92%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 24.0¢ | $59.66K | 241.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 78837 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 36290 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |